Clark Capital Management Group, Inc. Astrazeneca PLC Transaction History

Clark Capital Management Group, Inc.

$13.8 Billion
Q4 2024

A detailed history of Clark Capital Management Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 10,047 shares of AZN stock, worth $739,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,047

Previous 5,309 89.24%

Holding current value

$739,258

Previous $413,000 59.32%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $299,441 - $377,050	4,738 Added 89.24%	10,047 $658,000
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $10,350 - $11,828	-135 Reduced 2.48%	5,309 $413,000
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $19,775 - $23,925	296 Added 5.75%	5,444 $424,000
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $26,059 - $29,706	-427 Reduced 7.66%	5,148 $348,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $27,726 - $31,037	448 Added 8.74%	5,575 $375,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $9,597 - $10,611	-148 Reduced 2.81%	5,127 $347,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $19,574 - $21,226	-280 Reduced 5.04%	5,275 $377,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $20.9 Million - $23.7 Million	-330,991 Reduced 98.35%	5,555 $385,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $657,567 - $854,437	12,130 Added 3.74%	336,546 $22.8 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $6.79 Million - $17.4 Million	-128,053 Reduced 28.3%	324,416 $17.8 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $16.2 Million - $19.5 Million	-273,552 Reduced 37.68%	452,469 $29.9 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $954,985 - $1.15 Million	17,139 Added 2.42%	726,021 $48.2 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $31.5 Million - $37.2 Million	-582,821 Reduced 45.12%	708,882 $41.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $16.1 Million - $17.6 Million	290,249 Added 28.98%	1,291,703 $77.6 Million
Q2 2021 Aug 02, 2021	BUY	$48.42 - $60.18 $17.8 Million - $22.1 Million	367,294 Added 57.92%	1,001,454 $60 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $1.75 Million - $2.02 Million	-37,015 Reduced 5.51%	634,160 $31.5 Million
Q4 2020 Jan 26, 2021	BUY	$48.52 - $58.02 $32.6 Million - $38.9 Million	671,175 New	671,175 $33.6 Million

Others Institutions Holding AZN

# of Institutions

1,351

Shares Held

489M

Call Options Held

5.88M

Put Options Held

4.1M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.

Account

Clark Capital Management Group, Inc. Astrazeneca PLC Transaction History